Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Decks
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2026) | Investor deck | 38 slides | September 2026 |
| Phase 3 LUCIDITY Trial of Avexitide in PBH Topline Data Conference Call (August 2026) | Conference | 17 slides | Aug 18, 2026 |
| Investor Presentation (March 2026) | Investor deck | 41 slides | Mar 24, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 40 slides | Mar 3, 2026 |
| Investor Presentation (January 2026) | Investor deck | 40 slides | Jan 8, 2026 |
| Technical Presentation (2025) | Technical | 14 slides | 2025 |
| Technical Presentation (July 2024) | Technical | 27 slides | Jul 10, 2024 |
| Technical Presentation (2024) | Technical | 20 slides | 2024 |
| Corporate Update (July 2023) | Corporate update | 24 slides | Jul 26, 2023 |
| ENDO 2022 | Conference | 15 slides | Jun 11, 2022 |
| ENDO (Endocrine Society) | Conference | 6 slides |